These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8814771)

  • 1. Informed decisions about protecting and promoting public health: rationale for a National Human Exposure Assessment Survey.
    Sexton K; Callahan MA; Bryan EF; Saint CG; Wood WP
    J Expo Anal Environ Epidemiol; 1995; 5(3):233-56. PubMed ID: 8814771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating science and policy in a National Human Exposure Assessment Survey.
    Burke TA; Sexton K
    J Expo Anal Environ Epidemiol; 1995; 5(3):283-96. PubMed ID: 8814773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based exposure measurements in EPA region 5: a phase I field study in support of the National Human Exposure Assessment Survey.
    Pellizzari E; Lioy P; Quackenboss J; Whitmore R; Clayton A; Freeman N; Waldman J; Thomas K; Rodes C; Wilcosky T
    J Expo Anal Environ Epidemiol; 1995; 5(3):327-58. PubMed ID: 8814775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National exposure measurements for decisions to protect public health from environmental exposures.
    Pirkle JL; Osterloh J; Needham LL; Sampson EJ
    Int J Hyg Environ Health; 2005; 208(1-2):1-5. PubMed ID: 15881972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-based exposure measurements in Arizona: a phase I field study in support of the National Human Exposure Assessment Survey.
    Lebowitz MD; O'Rourke MK; Gordon S; Moschandreas DJ; Buckley T; Nishioka M
    J Expo Anal Environ Epidemiol; 1995; 5(3):297-325. PubMed ID: 8814774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An introduction to the National Human Exposure Assessment Survey (NHEXAS) and related phase I field studies.
    Sexton K; Kleffman DE; Callahan MA
    J Expo Anal Environ Epidemiol; 1995; 5(3):229-32. PubMed ID: 8814770
    [No Abstract]   [Full Text] [Related]  

  • 7. [The precautionary principle: advantages and risks].
    Tubiana M
    J Chir (Paris); 2001 Apr; 138(2):68-80. PubMed ID: 11319454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of important design issues for a National Human Exposure Assessment Survey.
    Callahan MA; Clickner RP; Whitmore RW; Kalton G; Sexton K
    J Expo Anal Environ Epidemiol; 1995; 5(3):257-82. PubMed ID: 8814772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of expert judgment in exposure assessment. Part I. Characterization of personal exposure to benzene.
    Walker KD; Evans JS; MacIntosh D
    J Expo Anal Environ Epidemiol; 2001; 11(4):308-22. PubMed ID: 11571610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Environmental data assessment for use in public health surveillance.
    Niskar AS
    J Environ Health; 2007 Nov; 70(4):43-5. PubMed ID: 18044253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National environmental public health tracking program: providing data for sound public health decisions.
    McGeehin MA
    J Public Health Manag Pract; 2008; 14(6):505-6. PubMed ID: 18849769
    [No Abstract]   [Full Text] [Related]  

  • 12. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding population and individual risk assessment: the case of polychlorinated biphenyls.
    Shields PG
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):830-9. PubMed ID: 16702358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The medical expenditure panel survey: a national information resource to support healthcare cost research and inform policy and practice.
    Cohen JW; Cohen SB; Banthin JS
    Med Care; 2009 Jul; 47(7 Suppl 1):S44-50. PubMed ID: 19536015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National Human Exposure Assessment Survey: analysis of exposure pathways and routes for arsenic and lead in EPA Region 5.
    Clayton CA; Pellizzari ED; Quackenboss JJ
    J Expo Anal Environ Epidemiol; 2002; 12(1):29-43. PubMed ID: 11859431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure apportionment: ranking food items by their contribution to dietary exposure.
    Moschandreas DJ; Karuchit S; Berry MR; O'Rourke MK; Lo D; Lebowitz MD; Robertson G
    J Expo Anal Environ Epidemiol; 2002 Jul; 12(4):233-43. PubMed ID: 12087429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk characterization: A bridge to informed decision making.
    North DW
    Fundam Appl Toxicol; 1997 Oct; 39(2):81-8. PubMed ID: 9344620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidisciplinary research: strategies for assessing chemical mixtures to reduce risk of exposure and disease.
    Suk WA; Olden K
    Int J Occup Med Environ Health; 2004; 17(1):103-10. PubMed ID: 15212212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Issues in applied statistics for public health bioterrorism surveillance using multiple data streams: research needs.
    Rolka H; Burkom H; Cooper GF; Kulldorff M; Madigan D; Wong WK
    Stat Med; 2007 Apr; 26(8):1834-56. PubMed ID: 17221940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.